Mutations in CLN12 (Park9), encoding the protein ATP13A2, result in juvenile-onset NCL in addition to Parkinson’s Disease type 9 (also referred to as Kufor-Rakeb syndrome) [164,165]. This evidence concerns the gene ATP13A2 and parkinsonism due to ATP13A2 deficiency.